US · Healthcare

Elixinol Global Ltd (ELLXF)

Drug Manufacturers - Specialty & Generic

Elixinol Global Ltd (ELLXF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ELLXF

P/E ratio

18.00

Elixinol Global Ltd (ELLXF) — FAQ

What is ELLXF's P/E ratio?

The price-to-earnings (P/E) ratio for Elixinol Global Ltd (ELLXF) is 18.00 (data as of 2026-03-24).

Does Elixinol Global Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Elixinol Global Ltd (ELLXF). Check the MyAverix Finance app for the latest dividend data.

What sector is Elixinol Global Ltd in?

Elixinol Global Ltd (ELLXF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ELLXF listed on?

ELLXF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)